101 related articles for article (PubMed ID: 28865215)
1. Survivin expression in correlation with apoptotic activity in canine lymphomas.
Sokołowska J; Urbańska K
Pol J Vet Sci; 2017 Mar; 20(2):329-338. PubMed ID: 28865215
[TBL] [Abstract][Full Text] [Related]
2. Survivin expression in canine lymphomas in relation with proliferative markers.
Sokołowska J; Urbańska K; Giziński S; Wysocka A; Cywińska A; Lechowski R
Pol J Vet Sci; 2015; 18(1):113-22. PubMed ID: 25928918
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical assessment of metalloproteinases MMP2 and MMP9 expression in canine various subtypes of lymphomas in relation with proliferative and apoptotic markers.
Sokołowska J; Urbańska K
Pol J Vet Sci; 2019 Jun; 22(2):203-211. PubMed ID: 31269334
[TBL] [Abstract][Full Text] [Related]
4. Survivin inhibition via EZN-3042 in canine lymphoma and osteosarcoma.
Shoeneman JK; Ehrhart EJ; Charles JB; Thamm DH
Vet Comp Oncol; 2016 Jun; 14(2):e45-57. PubMed ID: 24923332
[TBL] [Abstract][Full Text] [Related]
5. Survivin and related proteins in canine mammary tumors: immunohistochemical expression.
Bongiovanni L; Romanucci M; Malatesta D; D'Andrea A; Ciccarelli A; Della Salda L
Vet Pathol; 2015 Mar; 52(2):269-75. PubMed ID: 24686389
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of survivin expression in untreated and relapsed canine lymphoma.
Rebhun RB; Lana SE; Ehrhart EJ; Charles JB; Thamm DH
J Vet Intern Med; 2008; 22(4):989-95. PubMed ID: 18647159
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical investigation of cell cycle and apoptosis regulators (survivin, β-catenin, p53, caspase 3) in canine appendicular osteosarcoma.
Bongiovanni L; Mazzocchetti F; Malatesta D; Romanucci M; Ciccarelli A; Buracco P; De Maria R; Palmieri C; Martano M; Morello E; Maniscalco L; Della Salda L
BMC Vet Res; 2012 Jun; 8():78. PubMed ID: 22686277
[TBL] [Abstract][Full Text] [Related]
8. Survivin expression in canine epidermis and in canine and human cutaneous squamous cell carcinomas.
Bongiovanni L; Colombi I; Fortunato C; Della Salda L
Vet Dermatol; 2009 Oct; 20(5-6):369-76. PubMed ID: 20178473
[TBL] [Abstract][Full Text] [Related]
9. Prognostic utility of apoptosis index, Ki-67 and survivin expression in dogs with nasal carcinoma treated with orthovoltage radiation therapy.
Fu DR; Kato D; Watabe A; Endo Y; Kadosawa T
J Vet Med Sci; 2014 Nov; 76(11):1505-12. PubMed ID: 25452259
[TBL] [Abstract][Full Text] [Related]
10. Survivin, caspase-3 and MIB-1 expression in astrocytic tumors of various grades.
Lebelt A; Rutkowski R; Och W; Jaczun K; Dziemiańczyk-Pakieła D; Milewski R; Mariak Z; Reszeć J
Adv Med Sci; 2016 Sep; 61(2):237-243. PubMed ID: 26995334
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of survivin in canine lymphoma.
Wimmershoff J; Polkinghorne A; Grest P; Schade B; Marchal T; Keller SM; Guscetti F
J Comp Pathol; 2010 May; 142(4):311-22. PubMed ID: 20116802
[TBL] [Abstract][Full Text] [Related]
12. Variation of apoptotic and proliferative activity among lymphoma subtypes in dogs: A flow cytometric study.
Riondato F; Martini V; Melega M; Poggi A; Miniscalco B
Res Vet Sci; 2021 Mar; 135():324-328. PubMed ID: 33779558
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of P-glycoprotein in various subtypes of canine lymphomas.
Sokołowska J; Urbańska K; Giziński S; Zabielska K; Lechowski R
Pol J Vet Sci; 2015; 18(1):123-30. PubMed ID: 25928919
[TBL] [Abstract][Full Text] [Related]
14. Canine lymphomas: association of classification type, disease stage, tumor subtype, mitotic rate, and treatment with survival.
Valli VE; Kass PH; San Myint M; Scott F
Vet Pathol; 2013 Sep; 50(5):738-48. PubMed ID: 23444036
[TBL] [Abstract][Full Text] [Related]
15. Using lymph node fine needle aspirates for gene expression profiling of canine lymphoma.
Starkey MP; Murphy S
Vet Comp Oncol; 2010 Mar; 8(1):56-71. PubMed ID: 20230582
[TBL] [Abstract][Full Text] [Related]
16. Mutation of p53 Gene and Its Correlation with the Clinical Outcome in Dogs with Lymphoma.
Koshino A; Goto-Koshino Y; Setoguchi A; Ohno K; Tsujimoto H
J Vet Intern Med; 2016; 30(1):223-9. PubMed ID: 26678182
[TBL] [Abstract][Full Text] [Related]
17. Survivin messenger RNA levels in Epstein-Barr virus-positive patients with leukemic low-grade B-cell lymphomas expressing the latent membrane protein 1: evidence of apoptotic function?
Diamantopoulos PT; Polonyfi K; Sofotasiou M; Mantzourani M; Galanopoulos A; Spanakis N; Papadopoulou V; Kalala F; Iliakis T; Zareifi DS; Kodandreopoulou E; Vassilakopoulos T; Angelopoulou M; Siakantaris M; Terpos E; Variami E; Kollia P; Vaiopoulos G; Pangalis G; Viniou NA
Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):56-60. PubMed ID: 24262330
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma.
Ansell SM; Arendt BK; Grote DM; Jelinek DF; Novak AJ; Wellik LE; Remstein ED; Bennett CF; Fielding A
Leukemia; 2004 Mar; 18(3):616-23. PubMed ID: 14749704
[TBL] [Abstract][Full Text] [Related]
19. Huachansu mediates cell death in non-Hodgkin's lymphoma by induction of caspase-3 and inhibition of MAP kinase.
Efuet ET; Ding XP; Cartwright C; Pan Y; Cohen L; Yang P
Int J Oncol; 2015 Aug; 47(2):592-600. PubMed ID: 26062471
[TBL] [Abstract][Full Text] [Related]
20. Expression of O(6)-methylguanine-DNA methyltransferase causes lomustine resistance in canine lymphoma cells.
Kambayashi S; Minami K; Ogawa Y; Hamaji T; Hwang CC; Igase M; Hiraoka H; Miyama TS; Noguchi S; Baba K; Mizuno T; Okuda M
Can J Vet Res; 2015 Jul; 79(3):201-9. PubMed ID: 26130852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
